Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sikarin PCLBKK:SKR-R -0.63%90 Price-to-Tangible-Book is 2.19 as of Aug. 26, 2026. GuruFocus rates BKK:SKR-R with a GF Score™ of 90/100 and a GF Value™ of ฿8.11 (Fairly Valued). The stock has 5 warning signs investors should review. Among 503 Healthcare Providers & Services companies, Sikarin PCL ranks better than 56.06% on this metric.
As of today (2026-08-26), Sikarin PCL's share price is ฿7.85. Sikarin PCL's Tangible Book per Share of Jun. 2026 for the quarter that ended in Jun. 2026 was ฿3.59. Hence, Sikarin PCL's Price to Tangible Book Ratio of today is 2.19.
The historical rank and industry rank for Sikarin PCL's Price-to-Tangible-Book or its related term are showing as below:
BKK:SKR-R'
s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.9 Med: 2.83 Max: 5.91
Current: 2.17
During the past 13 years, Sikarin PCL's highest Price to Tangible Book Ratio was 5.91. The lowest was 1.90. And the median was 2.83.
BKK:SKR-R's Price-to-Tangible-Book is ranked better than 56.06% of 503
companies
in the Healthcare Providers & Services industry
Industry Median: 2.63
vs BKK:SKR-R: 2.17
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
Sikarin PCL Price-to-Tangible-Book Related Terms
Sikarin PCL Price-to-Tangible-Book Historical Data
* Premium members only.
The historical data trend for Sikarin PCL's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:SKR-R vs HCA, THC, DVA: Price-to-Tangible-Book Comparison
For the Medical Care Facilities subindustry, Sikarin PCL's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sikarin PCL Price-to-Tangible-Book vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Sikarin PCL's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where Sikarin PCL's Price-to-Tangible-Book falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Sikarin PCL (BKK:SKR-R) has a Price-to-Tangible-Book of 2.19 as of Aug. 26, 2026. Price-to-tangible-book ratio is the ratio of share price to a company's tangible book value per share. View historical data on Sikarin PCL and its competitors. According to the industry distribution chart, Sikarin PCL ranks #221 out of 503 companies in the Healthcare Providers & Services industry, placing it in the top 43.9%.
Is Sikarin PCL's Price-to-Tangible-Book too high?
Sikarin PCL's current Price-to-Tangible-Book is 2.19. The Healthcare Providers & Services industry median Price-to-Tangible-Book is 2.63. Sikarin PCL's value of 2.19 is 16.7% below this industry median. Based on the distribution chart, Sikarin PCL ranks #221 out of 503 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Sikarin PCL has a GF Score™ of 90/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sikarin PCL's Price-to-Tangible-Book compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Sikarin PCL ranks #221 out of 503 companies for Price-to-Tangible-Book. This puts Sikarin PCL in the upper half of its industry. The industry median Price-to-Tangible-Book is 2.63. Sikarin PCL's value of 2.19 is 16.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Price-to-Tangible-Book for a Healthcare Providers & Services company?
The median Price-to-Tangible-Book among Healthcare Providers & Services companies is 2.63, based on 503 companies in the industry. Companies in the top quartile (top 25%) have a Price-to-Tangible-Book significantly above this median, while those in the bottom quartile fall well below. However, Price-to-Tangible-Book should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sikarin PCL's current Price-to-Tangible-Book of 2.19 is 16.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Price-to-Tangible-Book mean?
A high Price-to-Tangible-Book can signal that a stock is expensive relative to its fundamentals. Price-to-tangible-book ratio is the ratio of share price to a company's tangible book value per share. View historical data on Sikarin PCL and its competitors. For the Healthcare Providers & Services industry, the median Price-to-Tangible-Book is 2.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sikarin PCL's current Price-to-Tangible-Book is 2.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sikarin PCL stock overvalued right now?
Based on GuruFocus' analysis, Sikarin PCL (BKK:SKR-R) is currently considered Fairly Valued. The stock's GF Value™ is ฿8.11, compared to a current price of ฿7.85 — trading 3.2% below its estimated fair value. The current Price-to-Tangible-Book is 2.19 and 16.7% below the Healthcare Providers & Services industry median of 2.63. Sikarin PCL's overall GF Score™ is 90/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Price-to-Tangible-Book calculated?
Price-to-Tangible-Book is calculated from a company's financial statements. For Sikarin PCL (BKK:SKR-R), the current Price-to-Tangible-Book is 2.19 as of Aug. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sikarin PCL (BKK:SKR-R) Overvalued in 2026?
Based on GuruFocus' analysis, Sikarin PCL stock appears to be undervalued.
The current stock price of ฿7.85 is trading 3.2% below its estimated GF Value™ of ฿8.11.
GuruFocus considers Sikarin PCL to be Fairly Valued.
Key valuation signals for BKK:SKR-R:
Price-to-Tangible-Book: 2.19
GF Value™: ฿8.11 vs. price of ฿7.85 (3.2% below fair value)
Industry Position: 16.7% below the Healthcare Providers & Services median (#221 of 503)
No single metric tells the full story. See the BKK:SKR-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SSikarin PCL provides general healthcare services and operates under the social security system. The Group has one main operating segment, which is providing healthcare services through private hospitals and hospitals affiliated with the social security system. The Group operates in a single geographical area, which is Thailand. Its services include medical centers, a pediatric center, a women's institute, a radiology center, a neurology center, a rehabilitation center, and an orthopedic center.
90GF Score
Get the complete analysis for BKK:SKR-R
Price-to-Tangible-Book is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:SKR-R has been successfully added to your 
